First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogenic blood transfusion in cardiovascular surgery - Görlinger, K; Dirkmann, D; Hanke, A A (Anesthesiology, 2011)
et al.